Hospitals Lost $48.4 Billion to Revenue Leakage in 2025 Despite Improving Cash Flow

Bypaulgruensfelder
BETAPrivate preview — this site is actively being built.
HealthLeaders Media April 2026
Read Full Article →
AI-Generated Summary

Kodiak Solutions analyzed data from 2,300 hospitals and 350,000 physicians and found that net revenue leakage — losses from final denials and uncollected bills — increased 25% in 2025 to $48.4 billion. Commercial plans were the leading source of leakage, with Medicare Advantage plans also aggressively denying and delaying claims. Despite the worsening leakage picture, cash flow metrics showed improvement as payers processed initial claims faster. The gap between better AR performance and rising net revenue losses reflects a strategic shift by payers: accelerating early processing while intensifying back-end denial activity.

Why It Matters

This isn’t just a revenue cycle problem — it’s a margin durability problem. If your system is posting decent AR days but leaking billions in final denials, the bottom line is eroding even when the front end looks healthy. The scale of this dataset (2,300 hospitals) makes it a credible benchmark for any CFO or RCM leader.

payer denials revenue leakage Medicare Advantage denials RCM automation hospital margin collections claims management

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Similar Posts

  • ASC M&A Activity Continues as Health Systems and PE Widen the Dealmaking Field

    Bypaulgruensfelder

    Ambulatory surgery center M&A deal flow is holding steady in 2026, with both private equity and health systems actively deploying capital at scale. USPI committed $125 million in Q1 2026 alone — acquiring seven ASCs and opening three de novos — while Surgery Partners is targeting approximately $200 million in annual capital deployment. VMG Health reports the median EBITDA multiple for ASC transactions reached 7.9x in 2025, the highest in at least eight years. Buyers are growing more selective, placing greater scrutiny on physician alignment, clinical operations, life-safety systems, and revenue cycle performance before committing to deals.

  • PwC Behind the Numbers 2027: Medical Cost Trend Hits 9%

    Bypaulgruensfelder

    Commercial medical cost trend is projected to reach 9% in 2027 — the highest in 17 years — according to PwC’s Behind the Numbers 2027 report. Five inflators drive the increase: AI-enabled tools that help providers capture more revenue (ranked a top-three inflator by 70% of health plans), rising provider reimbursement amid consolidation (hospital services inflation hit 7.59% year over year in February 2026), growing pharmacy spend (3.5 million GLP-1 prescriptions filled in December 2025, nearly double a year earlier), a 62.6% rise in behavioral health utilization from 2018 to 2024, and No Surprises Act arbitration, where providers win 88% of payment disputes. With external deflators largely exhausted, PwC argues payers must lean on benefit design, network design, and utilization management to bend the curve.

  • 6 Health Systems Outsourcing Revenue Cycle Functions in 2026

    Bypaulgruensfelder

    Six U.S. health systems—including IU Health, UnityPoint Health, and Stamford Health—moved revenue cycle functions to outside vendors in the first half of 2026, signaling that RCM outsourcing has become a core financial strategy rather than a last resort. IU Health partnered with Ensemble Health Partners on June 9, while UnityPoint shifted functions to Omega Healthcare amid rising labor, supply, and drug costs. Several deals transferred staff directly to vendors: Margaret Mary Health moved 53 employees to Revology, and Knox Community Hospital transferred 42 billing staff to Ovation Healthcare. The pattern reflects mounting margin pressure and a shift toward partners that promise end-to-end performance accountability and predictable cost structures.

  • 3 Investment Trends Shaping Behavioral Health Deals in 2026

    Bypaulgruensfelder

    Behavioral health M&A in 2026 is running slower than expected but deal activity continues. SUD treatment may be the most undervalued subsector, with deal flow at a six-year low yet clinically strong operators attracting renewed investor interest. Investors now require founders to retain equity and stay involved post-acquisition. With 90%+ of behavioral health still independently owned, consolidators see significant runway — if they can navigate Medicaid uncertainty from the One Big Beautiful Bill Act and exchange subsidy changes. Analysis from Lee Equity Partners, Mertz Taggart, and Beacon Behavioral Partners.

  • Dental M&A 2026: Ten Shifts DSO Leaders Must Understand Now

    Bypaulgruensfelder

    Dental M&A in 2026 has moved from growth at any cost to operational discipline, according to new data from TUSK Practice Sales. Although 69% of DSOs plan to increase acquisitions this year, a high-demand, low-supply market will make deals harder to close — TUSK expects this imbalance to persist for nine months. Several large DSOs, including Dental Care Alliance and Affordable Care, have transitioned into lender control following restructuring, signaling the limits of debt-fueled expansion. Meanwhile, private placement memorandum exits rose 57.1% last year, and 78% of DSOs anticipate recapitalization within 12–36 months. DSOs now require minimum 5-year post-close employment terms and are exiting deals over staffing and clinical continuity risks. The era of rapid network expansion is giving way to regional density, financial discipline, and technology investment.

  • JAMA Study: Ambient AI Scribes Boost RVUs 5.8% — The Real ROI Is Physician Retention

    Bypaulgruensfelder

    Ambient AI scribes at health systems generate measurable financial returns: a peer-reviewed JAMA Network Open study examining 1.2 million ambulatory encounters found access to an ambient AI scribe was associated with a 5.8% increase in weekly RVUs and 2.8% more encounters per week, with no increase in claim denials. At 2025 Medicare rates, 1.8 additional weekly RVUs translates to approximately $3,000 annually per physician. The stronger ROI case lies in workforce retention: ambient scribes reduce burnout by 20–40%, and each physician departure costs health systems $500,000–$1 million. Subscription costs run $200–$600 per clinician per month.